Full description
This dataset contains de identified participant level data from the NIV@Home pilot randomised controlled trial, which compared in home noninvasive ventilation (NIV) initiation with remote follow up against a single day hospital admission NIV initiation model in adults with neuromuscular disease, predominantly motor neurone disease (MND). The trial assessed feasibility, adherence to NIV over 12 weeks, health related quality of life, symptoms, carer burden, and participants' experiences of NIV initiation. Recruitment occurred between August 2020 and August 2021 during the COVID 19 pandemic, which influenced referral patterns, follow up, and hospital access. The dataset includes demographics, respiratory function, comorbidities, baseline assessments, randomisation strata, NIV settings, usage data (objective ventilator downloads), follow up contact logs, qualitative interview summaries, and outcome measures evaluating feasibility and adherence. The dataset supports evaluation of alternative models of NIV initiation and contributes to the evidence base for home based respiratory care in neuromuscular disease. Publication DOI: 10.1080/21678421.2024.2416668Notes
HeSANDA 1.0.0Created: 2026-03-26
Updated: 2026-03-26
Issued: 2026-03-26
Collected:
Data time period: 2020 to , 2021 to ,
Spatial Coverage And Location
text: Austin Health - Austin Hospital - Heidelberg
Subjects
Health services and systems not elsewhere classified |
Intensive care |
Neurology and neuromuscular diseases |
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Identifiers
- DOI : 10.26188/31856506
